Imprint
Imprint
Information pursuant to Section 5 of the German Digital Services Act (Digitale-Dienste-Gesetz – DDG)
THCA Therapeutics
Business owner / sole proprietor:
Farbod Parvin
Wildenrother Str. 15
81245 Munich
Germany
Contact
Email: info@thcatherapeutics.com
Telephone: +49 174 6617652
Website: www.thcatherapeutics.com
Legal status
THCA Therapeutics is a business name used by Farbod Parvin in operating a sole proprietorship. Farbod Parvin is the responsible business owner and contracting party.
The designation “THCA Therapeutics” is used as a project and business name. Any references on this website to planned corporate structures, development programs, products, research activities, financing, partnerships or regulatory pathways describe current intentions and development plans only.
Person responsible for editorial content
Responsible pursuant to Section 18(2) of the German State Media Treaty (Medienstaatsvertrag – MStV), where applicable:
Farbod Parvin
Wildenrother Str. 15
81245 Munich
Germany
Medical and scientific information
The information presented on this website is provided for general scientific, corporate and informational purposes only. It does not constitute medical advice, diagnosis, treatment advice or a recommendation to use any product or substance.
THCA Therapeutics does not currently market an approved medicinal product. THCA PURE™ and other described product concepts remain under development. Statements concerning potential therapeutic properties are based on scientific hypotheses, published literature, preclinical findings or planned research unless expressly stated otherwise.
Preclinical findings do not establish safety or efficacy in humans. No person should make medical decisions or alter treatment based on information provided on this website. Medical questions should be directed to an appropriately qualified healthcare professional.
Regulatory notice
Any medicinal product, clinical-development program or therapeutic application described on this website remains subject to scientific validation, regulatory review and, where required, authorization by the competent authorities.
No statement on this website should be interpreted as confirming regulatory approval, clinical efficacy, safety, market authorization or commercial availability.
Liability for content
We prepare the content of this website with reasonable care. However, we do not guarantee that the information is complete, accurate or current.
Scientific, regulatory and commercial information may change as research progresses, new evidence becomes available or applicable requirements are updated. General legal obligations to remove or restrict unlawful content remain unaffected.
Liability for external links
This website may contain links to third-party websites. We do not control the content or data-processing practices of those websites and therefore cannot accept responsibility for their content.
The respective third-party provider is responsible for the content of linked websites. If we become aware of a specific legal violation, we will review and, where appropriate, remove the relevant link.
Copyright
Unless otherwise stated, the content and materials created for this website are protected by applicable copyright law.
Reproduction, editing, distribution or other use beyond what is permitted by law requires prior written authorization from the relevant rights holder.
Third-party content is identified where reasonably possible. Please notify us if you believe that material appearing on this website infringes your rights.
Trademarks and product names
THCA Therapeutics and THCA PURE™ are used as project, brand and product-development names.
The use of the ™ symbol does not represent that a trademark has necessarily been registered. Third-party trademarks and trade names remain the property of their respective owners.
Consumer dispute resolution
We are neither willing nor obliged to participate in dispute-resolution proceedings before a consumer arbitration body.
Effective date
Effective as of: July 2026
